India finds 1,420 substandard drug samples in first half of ‘11
In the first six months of fiscal 2011 tests of drug samples found 1,420 substandard pharmaceuticals in India.
Archives for March 27, 2012
News from Delcath, Genesis and Intarcia – People on the move
in-PharmaTechnologist present its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Delcath, Genesis and Intarcia.
Oncology trials take 50% longer than other therapeutics; report
Oncology clinical trials take 50 per cent longer to go from protocol approval to randomisation of the last subject, a report found.
INC Research to close former Kendle office with loss of 66 jobs
US CRO INC Research will close an office it gained through its acquisition of Kendle International last year.
Strategic deals boost satisfaction levels but CROs still need to deliver on costs
New research suggests that – in general - strategic partnerships are working but CROs still need to improve on sponsors’ ‘high priority’ objectives or risk losing deals.
Warnex says suitors interested in remaining divisions
Contract services firm Warnex says its analytical and bioanalytical divisions have attracted ‘interest’ from buyers that would exceed its current market cap.
FDA hits two Mexican firms with GMP warning letters
The FDA has hit two Mexican companies with GMP warning letters six months after inspectors visited the country.